These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 3675957)
1. Polymethylmethacrylate in chronic hemodialysis. Is it of benefit in patients with uremic neuropathy? Di Paolo B; Di Marco T; Cappelli P; Albertazzi A ASAIO Trans; 1987; 33(3):293-6. PubMed ID: 3675957 [No Abstract] [Full Text] [Related]
2. Rapid improvement of uremic neuropathy on short high-efficiency hemodialysis with special reference to middle molecules. Manohar NL; Gorfien PC; Namba T; Louis BM; Lipner HI ASAIO Trans; 1987; 33(3):274-9. PubMed ID: 3675953 [No Abstract] [Full Text] [Related]
3. The effects of hemodialysis with different membranes on middle molecules and uremic neuropathy. Djukanović LJ; Mimić-Oka JI; Potić JB Int J Artif Organs; 1989 Jan; 12(1):11-9. PubMed ID: 2538398 [TBL] [Abstract][Full Text] [Related]
4. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients. Valeri A; Radhakrishnan J; Ryan R; Powell D Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557 [TBL] [Abstract][Full Text] [Related]
5. Effect of dialysis dose and membrane flux in maintenance hemodialysis. Locatelli F N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691051 [No Abstract] [Full Text] [Related]
13. [Neuropsychiatric disorders of patients in the terminal stages of chronic renal failure]. Martynov IuS; Vantsian OIu Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(11):54-9. PubMed ID: 6758445 [No Abstract] [Full Text] [Related]
14. Blood levels of middle molecules and their effects on motor nerve conduction velocity. Botella J; Gea T; Sanz-Guajardo D; Criado M; Torres MT; Guardiola J Artif Organs; 1981; 4 Suppl():151-5. PubMed ID: 7295082 [TBL] [Abstract][Full Text] [Related]
15. [Complications and problems in hemodialysis of chronic kidney failure important in clinical practice]. Würz H; Euchenhofer M; Streicher E Z Allgemeinmed; 1971 May; 47(13):692-9. PubMed ID: 5580601 [No Abstract] [Full Text] [Related]
16. Are biocompatible membranes superior for hemodialysis therapy? van Ypersele de Strihou C Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694 [No Abstract] [Full Text] [Related]
17. Uremic neuropathy. Monitoring of transketolase activity inhibition in a child. McVicar M; Gauthier B; Goodman CT Am J Dis Child; 1973 Feb; 125(2):263-5. PubMed ID: 4265477 [No Abstract] [Full Text] [Related]
18. Effect of dialysis dose and membrane flux in maintenance hemodialysis. Friedman EA N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691049 [No Abstract] [Full Text] [Related]
19. [Influence of dialysis membranes on lipid parameters]. de Précigout V Nephrologie; 2000; 21(7):359-60. PubMed ID: 11200611 [No Abstract] [Full Text] [Related]